LabCorp Announces Definitive Agreement to Acquire Orchid Cellmark for $2.80 per Share

Laboratory Corporation of America® Holdings LH and Orchid Cellmark Inc. ORCH today announced that they have entered into a definitive agreement and plan of merger under which LabCorp will acquire all of the outstanding shares of Orchid Cellmark in a cash tender offer for $2.80 per share for a total purchase price to stockholders and optionholders of approximately $85.4 million. Orchid Cellmark strengthens LabCorp's presence and strong brand name in identity testing in the US and establishes its presence in identity testing in the UK.